Combined CAR-T Congress Europe gathers thought leaders from biotech, big pharma, academia and the wider service community to address the challenges and opportunities of CAR-T therapies – including CAR-T, CAR-Tregs and combined therapies - that are critical to furthering the development of viable T-cell therapies. 

Human Gene Therapy is the premier, multidisciplinary journal covering all aspects of gene therapy. The Journal publishes in-depth coverage of DNA, RNA, and cell therapies by delivering the latest breakthroughs in research and technologies.The Journal is divided into three parts.

Human Gene Therapy, the flagship, is published 12 times per year.

HGT Methods, a bimonthly journal, focuses on the applications of gene therapy to product testing and development. HGT Clinical Development, a quarterly journal, serves as a venue for publishing data relevant to the regulatory review and commercial development of cell and gene therapy products. 

Pick up your copy of the essential resource at the Combined CAR-T Congress Europe.